NCRI Press Release, 9 November 2016
Marker for aggressive prostate cancer doubles-up as a drug target
Download the attachment-
RT @Mesouk : Help shape the future of #cancer #research by taking part in a survey by the Nat'l Cancer Research Institute. Open until 25 Apr…
3 days ago -
RT @ecancer : Registration and abstract submission for the 2018 @NCRI_partners Cancer Conference is now live! Sign up today to discover the…
3 days ago -
RT @drol007 : Second chance at @LindAlliance @NCRI_partners survey https://t.co/j51JVamVr7
4 days ago
What's Happening
- 16 Apr 2018Job vacancy: Policy Officer, Tenovus Cancer Care
- 13 Apr 2018Call for Proposals: NCRI Screening Prevention & Early Diagnosis (SPED) Workshop - 6 June 2018
- 11 Apr 2018Call for proposals: NCRI Lung Cancer CSG Trials Meeting - 13 June 2018
- 5 Apr 2018NCRI job opportunity: Data Analyst
- 21 Mar 2018Register for the NCRI Lung Cancer Clinical Studies Group Trials Meeting: 13 June 2018
- 21 Feb 2018NCRI Cancer CTU Group releases new guidelines
- 9 Feb 2018Important news – NCRI's Director, Dr Karen Kennedy, to leave the organisation
RSS Feed